Related Experiment Videos
Immunomodulation of experimental antiphospholipid syndrome
Y Sherer1, M Blank, Y Shoenfeld
1Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Scandinavian Journal of Rheumatology. Supplement
|October 6, 1998
Summary
Experimental treatments for antiphospholipid syndrome (APS) in animal models show promise. This review covers bone marrow transplantation, immunotherapies, and anti-coagulant agents, exploring their mechanisms and clinical relevance for APS.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications.
- Animal models are crucial for evaluating novel therapeutic strategies for APS that cannot be tested in human patients.
- Understanding the efficacy and mechanisms of various treatments in experimental settings is vital for advancing APS therapy.
Purpose of the Study:
- To review therapeutic modalities investigated in experimental antiphospholipid syndrome models.
- To analyze the mechanisms of action of these experimental treatments.
- To discuss the potential clinical implications of these findings for human APS patients.
Main Methods:
- Literature review of studies utilizing animal models of antiphospholipid syndrome.
- Analysis of reported therapeutic interventions, including bone marrow transplantation, monoclonal antibodies, and pharmacological agents.
- Examination of data on treatment efficacy, mechanisms, and translational potential.
Main Results:
- Bone marrow transplantation, anti-CD4 monoclonal antibodies, bromocriptine, intravenous immunoglobulins, anti-idiotypes, and interleukin-3 have demonstrated benefits in experimental APS.
- Various anti-coagulant and anti-aggregate agents are also effective in managing thrombotic aspects of experimental APS.
- These treatments target different pathways involved in the pathogenesis of APS.
Conclusions:
- A range of therapeutic agents show efficacy in preclinical models of antiphospholipid syndrome.
- Further research into the mechanisms and clinical translation of these findings is warranted.
- Experimental models provide a valuable platform for developing and testing new APS treatments.